FDA to Review Over 950 Food Additives Amid Rising Health Concerns
In a significant move, the U.S. Food and Drug Administration (FDA) has announced plans to intensify its oversight of chemicals in the U.S. food supply, transitioning from a historically reactive role to a more proactive evaluation process. This initiative aims to address the presence of over 950 additives currently permitted in the U.S. but banned in the European Union, highlighting a substantial regulatory gap.
Acting Deputy Commissioner for Human Foods, Kyle Diamantas, revealed that the FDA will update its priority list of chemicals for review, focusing on substances like butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), and azodicarbonamide (ADA). ADA, often referred to as the “yoga mat chemical,” is used in bread and baked goods and has been banned in several countries due to potential health risks.
This initiative aligns with Health Secretary Robert F. Kennedy Jr.’s broader campaign to combat chronic illnesses by improving the national diet. Kennedy has emphasized the need to eliminate synthetic food colors and promote healthier alternatives, such as natural food dyes derived from red algae and butterfly pea flower extract.
The FDA plans to release a framework for identifying additional chemicals for review, inviting public input later this month. This approach aims to incorporate international data and public concerns, ensuring a comprehensive evaluation process.
As the FDA embarks on this extensive review, consumers are encouraged to stay informed and make conscious choices about the products they consume.
2026-07-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
HighChem and Jiangxi Zhongxin Aksum Launch HFO-1233zd in Japan Low GWP and Zero ODP Products Target Surging Insulation and Semiconductor Demand
-
EFSA Reviews Clodinafop Risk
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
Cabot Launches 95F Conductive Additive to Boost Lithium Battery Life for Energy Storage Demands Soar
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
Recommend Reading
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
GM Crop Area Reaches 216 Million Hectares
-
Natural Rubber Market Trends Have Been Volatile and Consolidating Since July
-
Strong Cost Support Drives Continued Strength in PTA Prices
-
Insufficient Spot Buying Interest, Acrylonitrile Market Slips Again in China
-
Demand Changes Lead to Initial Drop and Then Rise in Butadiene Prices
-
Supply and Demand Game, Toluene Market Trend Stabilizes in China